Companies 0 See All
Hedge Funds 0 See All
Insiders 0 See All
Institutional Investors 0 See All
Click here to see all results for
Home > Insider Trading > Daniel Tasse > Profile

Daniel Tasse

Affiliations

  • at Regenxbio Inc. (RGNX), 2024-06-04
  • Chief Executive Officer at Dbv Technologies S.a. (DBVT), 2024-03-11
  • Director at Bellerophon Therapeutics Inc. (BLPH), 2018-06-25
  • Interim Pres-Hospital Business at Mallinckrodt Plc (MNK), 2015-05-04
Insider Trading: Purchases See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
Dbv Technologies S.a.
 DBVT $0.83 17,094 17,094 2024-03-08 Filing
Bellerophon Therapeutics Inc.
 BLPH $12.00 25,000 Director 128,898 2015-02-19 Filing